Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boulder, CO
SEC filing record 1 source field available
Fiscal year end
31 March
Sonoma Pharmaceuticals, Inc. has filed 974 SEC EDGAR filings since 15 Jan 2002

SEC filing history

Showing 176-200 of 746 matching filings.

Per page
25
Current page
8
424B3 File 333-250925

FORM 424B3

Filing date
03 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-33216

OTHER PROXY INFORMATION

Filing date
30 Aug 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-33216

OTHER PROXY MATERIALS

Filing date
23 Aug 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-33216

FORM 10-Q FOR JUNE 30, 2021

Filing date
16 Aug 2021
Reporting date
30 Jun 2021
Next action
Verify source filing
DEFA14A File 001-33216

DEF14A ADDITIONAL MATERIAL

Filing date
16 Aug 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33216

FORM 8-K

Filing date
02 Aug 2021
Reporting date
27 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33216

FORM 8-K

Filing date
30 Jul 2021
Reporting date
30 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-250925

PROSPECTUS SUPPLEMENT

Filing date
30 Jul 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-33216

DEFINITIVE PROXY STATEMENT

Filing date
29 Jul 2021
Reporting date
15 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33216

FORM 8-K

Filing date
20 Jul 2021
Reporting date
15 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33216

CURRENT REPORT

Filing date
09 Jul 2021
Reporting date
05 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33216

FORM 8-K

Filing date
06 Jul 2021
Reporting date
01 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-K File 001-33216

NOTIFICATION OF LATE FILING

Filing date
29 Jun 2021
Reporting date
31 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33216

FORM 8-K

Filing date
31 Mar 2021
Reporting date
26 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33216

CURRENT REPORT

Filing date
04 Mar 2021
Reporting date
04 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-33216

QUARTERLY REPORT

Filing date
16 Feb 2021
Reporting date
31 Dec 2020
Next action
Verify source filing
4

4 filing

Filing date
13 Jan 2021
Reporting date
07 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33216

FORM 8-K

Filing date
11 Jan 2021
Reporting date
11 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
08 Jan 2021
Reporting date
07 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
08 Jan 2021
Reporting date
07 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33216

FORM 8-K

Filing date
08 Jan 2021
Reporting date
04 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-250925

PROSPECTUS SUPPLEMENT

Filing date
23 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .